Wilms Tumor  >>  Votrient (pazopanib)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Votrient (pazopanib) / Novartis, BeiGene
NCT01130623: A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors

Withdrawn
1
0
US
Pazopanib (GW786034)
National Cancer Institute (NCI)
Sarcoma, Neuroblastoma, Wilms Tumor, Osteosarcoma, Brain Tumor
11/11
11/11

Download Options